Synchron
3 known investors
Synchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline. The company serves patients with motor impairment and cognitive decline using a minimally invasive approach inspired by cardiac interventional procedures.
Investors · 3
In the news
- Synchron raises $200M to prepare for brain computer interface launch | MedTech Divemedtechdive.com · 2025
- Synchron Raises $200M in Series D Fundingfinsmes.com · 2025
- Synchron raises $200M Series D to support BCI commercialization, next-gen techmassdevice.com · 2025
- Synchron Raises $200 Million Series D to Advance Brain-Computer Interface Technologybusinesswire.com · 2025
- Sell or Invest in Synchron Stock Pre-IPOnasdaqprivatemarket.com · 2025
- Synchron - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2021